Understanding the risks of infections from pets to humans
Assessment of Zoonotic Risk of Emerging Infections in Companion Animals
This study is looking at how certain germs, like E. coli and coronaviruses, can be passed from pets to people, and it aims to find out if these germs could make us sick by examining their genetic traits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project ID | NIH-10900447 on NIH RePORTER |
What this research studies
This research investigates the potential health risks posed by certain pathogens, specifically E. coli and coronaviruses, that can be transmitted from companion animals to humans. By analyzing the genetic makeup of E. coli found in dogs, the study aims to identify any novel resistance mechanisms that could lead to disease in humans. Additionally, the research will explore the diversity of coronaviruses in pets to better understand their potential impact on human health. This work utilizes advanced genomic analysis techniques to assess the risks associated with these pathogens.
Who could benefit from this research
Good fit: Ideal candidates for this research include pet owners, particularly those with dogs, who may be concerned about the health risks associated with zoonotic infections.
Not a fit: Patients who do not own pets or have no exposure to companion animals may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and prevention of zoonotic infections that can be transmitted from pets to humans.
How similar studies have performed: Previous research has shown success in understanding zoonotic diseases through genomic analysis, indicating that this approach has potential for impactful findings.
Where this research is happening
Ithaca, United States
- Cornell University — Ithaca, United States (Active)
Researchers
- Principal investigator: Goodman, Laura Brunengraber — Cornell University
- Study coordinator: Goodman, Laura Brunengraber
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.